These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22197383)

  • 1. Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer.
    Linxweiler M; Linxweiler J; Barth M; Benedix J; Jung V; Kim YJ; Bohle RM; Zimmermann R; Greiner M
    Am J Pathol; 2012 Feb; 180(2):473-83. PubMed ID: 22197383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.
    Jung V; Kindich R; Kamradt J; Jung M; Müller M; Schulz WA; Engers R; Unteregger G; Stöckle M; Zimmermann R; Wullich B
    Mol Cancer Res; 2006 Mar; 4(3):169-76. PubMed ID: 16547154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells.
    Linxweiler M; Schorr S; Schäuble N; Jung M; Linxweiler J; Langer F; Schäfers HJ; Cavalié A; Zimmermann R; Greiner M
    BMC Cancer; 2013 Dec; 13():574. PubMed ID: 24304694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.
    Linxweiler M; Bochen F; Schick B; Wemmert S; Al Kadah B; Greiner M; Hasenfus A; Bohle RM; Juhasz-Böss I; Solomayer EF; Takacs ZF
    BMC Cancer; 2016 Aug; 16(1):676. PubMed ID: 27553742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
    Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
    Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sec62 protein level is crucial for the ER stress tolerance of prostate cancer.
    Greiner M; Kreutzer B; Lang S; Jung V; Cavalié A; Unteregger G; Zimmermann R; Wullich B
    Prostate; 2011 Jul; 71(10):1074-83. PubMed ID: 21557272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
    Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
    Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
    Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
    Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
    Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bag3 promotes resistance to apoptosis through Bcl-2 family members in non-small cell lung cancer.
    Zhang Y; Wang JH; Lu Q; Wang YJ
    Oncol Rep; 2012 Jan; 27(1):109-13. PubMed ID: 21971866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma.
    Shinmura K; Tao H; Nagura K; Goto M; Matsuura S; Mochizuki T; Suzuki K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
    Lung Cancer; 2011 Jan; 71(1):19-27. PubMed ID: 20434789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleted in pancreatic carcinoma locus 4/Smad4 participates in the regulation of apoptosis by affecting the Bcl-2/Bax balance in non-small cell lung cancer.
    Ke Z; Zhang X; Ma L; Wang L
    Hum Pathol; 2008 Oct; 39(10):1438-45. PubMed ID: 18620728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
    Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
    Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA2 overexpression in non-small cell lung cancer.
    Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
    Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.